|
|
Volumn 66, Issue 5, 1999, Pages 285-292
|
|
COX 2-selective NSAIDs: Biology, promises, and concerns
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CITALOPRAM;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
DICLOFENAC;
FOSPHENYTOIN SODIUM;
IBUPROFEN;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
UNCLASSIFIED DRUG;
WARFARIN;
ANTIINFLAMMATORY ACTIVITY;
BLEEDING;
CHRONIC PAIN;
DIGESTIVE SYSTEM ULCER;
DRUG CONTRAINDICATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG SAFETY;
DRUG SELECTIVITY;
GOUT;
HUMAN;
MIGRAINE;
OSTEOARTHRITIS;
REVIEW;
RHEUMATOID ARTHRITIS;
RISK FACTOR;
THROMBOCYTE FUNCTION;
|
|
EID: 0032926879
PISSN: 08911150
EISSN: None
Source Type: Journal
DOI: 10.3949/ccjm.66.5.285 Document Type: Review |
|
Times cited : (40)
|
|
References (17)
|
